Cargando…
Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis
BACKGROUND: Carcinoma of the thyroid gland is an uncommon cancer, but the most frequent malignancy of the endocrine system. Most thyroid cancers are derived from the follicular cell. Follicular carcinoma (FTC) is considered more malignant than papillary thyroid carcinoma (PTC), and anaplastic thyroi...
Autores principales: | McLaughlin, Patricia J, Zagon, Ian S, Park, Sunny S, Conway, Andrea, Donahue, Renee N, Goldenberg, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770570/ https://www.ncbi.nlm.nih.gov/pubmed/19835629 http://dx.doi.org/10.1186/1471-2407-9-369 |
Ejemplares similares
-
The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer
por: Cheng, Fan, et al.
Publicado: (2008) -
Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the OGF-OGFr Pathway
por: Zagon, Ian S., et al.
Publicado: (2022) -
Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats
por: Purushothaman, Indira, et al.
Publicado: (2021) -
Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats
por: McLaughlin, Patricia J., et al.
Publicado: (2023) -
The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture
por: Sassani, Joseph W., et al.
Publicado: (2016)